[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Home Healthcare Market by Product (Dialysis Equipment, Ventilators, ECG, Canes, Wheelchairs, Activity Monitors, Nebulizers, BP Monitors), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication, Region - Global Forecast to 2025

October 2020 | 246 pages | ID: HF9FBF036A9EN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
The global home healthcare market size is projected to reach USD 274.7 billion by 2025 from USD 181.9 billion in 2020, at a CAGR of 8.6% during the forecast period. The market growth is mainly driven by factors such as the rapid growth in the elderly population and the rising incidence of chronic diseases, growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements in-home care devices. On the other hand, changing reimbursement policies, limited insurance coverage, and concerns regarding patient safety are factors limiting the growth of the market to a certain extent. The growing popularity of telehealth and untapped developing regions present significant growth opportunities for players in the home healthcare market.

“The cancer segment is expected to dominate the market during the forecast period.”

Based on indication, the global home healthcare market is segmented into cancer, respiratory diseases, mobility disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. The cancer segment accounted for the largest share of the home healthcare market in 2019. The large share of this segment can primarily be attributed to the high prevalence of cancer cases across the globe and the transforming healthcare system, which allows the management of cancer at home.

“Testing, screening & monitoring segment will witness the highest growth in the home healthcare products market.”

Based on products, the home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. The testing, screening, and monitoring products are expected to witness the highest CAGR during the forecast period. The high growth of this segment can primarily be attributed to factors such as the rising emphasis on preventive medicine and an increasing number of patients with chronic diseases. The potential to reduce healthcare complications and ensure the portability of devices with high accuracy is also expected to create a significant demand for monitoring and testing devices in the coming year.

“North America will dominate the market during the forecast period.”

Geographically, the home healthcare market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the home healthcare market. The large share of this region in the global market is attributed to the rising prevalence of chronic conditions, high healthcare expenditure, high disposable income, the increasing overall geriatric population, high disposable income, and the presence of superior healthcare infrastructure.

The primary interviews conducted for this report can be categorized as follows:
  • By Company Type - Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
  • By Designation - C-level: 33%, D-level: 40%, and Others: 27%
  • By Region - North America: 36%, Europe: 28%, Asia Pacific: 19%, and Rest of the World: 17%
List of Companies Profiled in the Report
  • Fresenius SE & Co. KGaA (Germany)
  • GE Healthcare (US)
  • Linde plc (Ireland)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • A&D Company (Japan)
  • BAYADA Home Health Care (US)
  • Invacare Corporation (US)
  • Abbott (US), Amedisys (US)
  • Kindred at Home (US)
  • LHC Group, Inc. (US)
  • OMRON Corporation (Japan)
  • Koninklijke Philips N.V. (Netherlands)
  • Drive DeVilbiss Healthcare (US)
  • Hamilton Medical (Switzerland)
  • Sunrise Medical (Germany)
  • Roma Medical (UK)
  • Caremax Rehabilitation Equipment Co., Ltd(China)
  • Vitalograph (UK)
  • advita Pflegedienst GmbH (Germany)
  • RENAFAN GmbH (Germany)
  • ADMR (France)
  • Apex Medical Corporation (Taiwan)
  • CONTEC MEDICAL SYSTEMS CO., LTD (China)
  • L?wenstein Medical Technology GmbH + Co. KG. (Germany)
Research Coverage:

This report provides a detailed picture of the global home healthcare market. It aims at estimating the size and future growth potential of the market across different segments, such as product, service, indication, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total home healthcare market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on home healthcare products and services offered by the top 25 players in the home healthcare market. The report analyses the home healthcare market by product, service, indication, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various home healthcare across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the home healthcare market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the home healthcare market.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
FIGURE 1 HOME HEALTHCARE MARKET SEGMENTATION
  1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.2 SECONDARY DATA
  2.2.1 SECONDARY SOURCES
2.3 PRIMARY DATA
  2.3.1 KEY DATA FROM PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.4 MARKET SIZE ESTIMATION
  2.4.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  2.4.2 TOP-DOWN APPROACH
FIGURE 5 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  2.4.3 GROWTH FORECAST
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

FIGURE 7 HOME HEALTHCARE MARKET, BY TYPE, 2020 VS. 2025 (USD BILLION)
FIGURE 8 HOME HEALTHCARE MARKET, BY PRODUCT, 2020 VS. 2025 (USD BILLION)
FIGURE 9 HOME HEALTHCARE MARKET, BY SERVICE, 2020–2025 (USD BILLION)
FIGURE 10 HOME HEALTHCARE MARKET, BY INDICATION, 2020 VS. 2025 (USD BILLION)
FIGURE 11 GEOGRAPHIC SNAPSHOT OF THE GLOBAL HOME HEALTHCARE MARKET

4 PREMIUM INSIGHTS

4.1 HOME HEALTHCARE MARKET OVERVIEW
FIGURE 12 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET
GROWTH DURING THE FORECAST PERIOD
4.2 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY MOBILITY CARE PRODUCT
AND COUNTRY (2019)
FIGURE 13 WHEELCHAIRS DOMINATED THE MOBILITY CARE PRODUCTS MARKET
IN ASIA PACIFIC IN 2019
4.3 HOME HEALTHCARE MARKET, BY SERVICE, 2019
FIGURE 14 INFUSION THERAPY SERVICES TO WITNESS THE HIGHEST GROWTH
RATE DURING THE FORECAST PERIOD (2020-2025)
4.4 HOME HEALTHCARE MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 15 JAPAN TO REGISTER THE FASTEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  5.2.1 MARKET DRIVERS
    5.2.1.1 Rising aging population, high incidence of chronic diseases, and need to expand healthcare access
TABLE 1 GLOBAL OVERVIEW OF THE RISE IN AGING POPULATION (MILLION)
    5.2.1.2 Technological advancements
    5.2.1.3 Increasing healthcare costs and the growing need for
affordable treatment options
  5.2.2 RESTRAINTS
    5.2.2.1 Changing reimbursement policies
    5.2.2.2 Limited insurance coverage
    5.2.2.3 Patient safety concerns
  5.2.3 OPPORTUNITIES
    5.2.3.1 Rising focus on telehealth
    5.2.3.2 Untapped developing regions
  5.2.4 CHALLENGES
    5.2.4.1 Shortage of home care workers
  5.2.5 COVID-19 IMPACT
5.3 PRICING ANALYSIS
5.4 VALUE CHAIN ANALYSIS
FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND
ASSEMBLY PHASES
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 18 DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES
5.6 ECOSYSTEM ANALYSIS OF THE MEDICAL DEVICES MARKET
FIGURE 19 ECOSYSTEM ANALYSIS OF THE MEDICAL DEVICES MARKET

6 HOME HEALTHCARE MARKET, BY PRODUCT

6.1 INTRODUCTION
TABLE 2 HOME HEALTHCARE MARKET, BY PRODUCT, 2018–2025 (USD BILLION)
TABLE 3 HOME HEALTHCARE PRODUCTS MARKET, BY REGION, 2018–2025 (USD BILLION)
6.2 THERAPEUTIC
TABLE 4 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 5 HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY REGION, 2018–2025 (USD BILLION)
  6.2.1 DIALYSIS EQUIPMENT
    6.2.1.1 Dialysis equipment have gained significance due to their improved clinical outcomes and better quality of life for patients
TABLE 6 DIALYSIS EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.2 WOUND CARE PRODUCTS
    6.2.2.1 Decreased cost and higher convenience and comfort of home
care will ensure the growth of this segment
TABLE 7 WOUND CARE PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.3 IV EQUIPMENT
    6.2.3.1 IV equipment facilitate the delivery of antibiotics, fluid replacements, and chemotherapy with accuracy
TABLE 8 IV EQUIPMENT MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.4 SLEEP APNEA THERAPEUTIC DEVICES
    6.2.4.1 Rising number of obstructive sleep apnea (OSA) cases and the growing prevalence of sleep disorders to drive the market
for sleep apnea therapeutic devices
TABLE 9 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.5 INSULIN DELIVERY DEVICES
    6.2.5.1 High incidence of diabetes to drive the insulin delivery
devices market
TABLE 10 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.6 OXYGEN DELIVERY SYSTEMS
    6.2.6.1 Technological advancements of oxygen therapy products
to drive the market
TABLE 11 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.7 INHALERS
    6.2.7.1 High incidence of asthma is the major factor driving
the inhalers market
TABLE 12 INHALERS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.8 NEBULIZERS
    6.2.8.1 Nebulizers are more effective as compared to oral dosages
TABLE 13 NEBULIZERS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.9 VENTILATORS
    6.2.9.1 Growing use of positive airway pressure devices for sleep apnea therapy is the key driver for the growth of the ventilators market in home care
TABLE 14 VENTILATORS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.2.10 OTHER THERAPEUTIC PRODUCTS
TABLE 15 OTHER THERAPEUTIC PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS
TABLE 16 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 17 HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2018–2025 (USD BILLION)
  6.3.1 BLOOD GLUCOSE MONITORS
    6.3.1.1 Increasing prevalence of diabetes to drive the market growth
TABLE 18 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.2 HEARING AIDS
    6.3.2.1 High incidence of hearing impairment to drive the market
TABLE 19 HEARING AIDS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.3 BLOOD PRESSURE MONITORS
    6.3.3.1 Increasing number of patients with hypertension and amplified occurrence of cardiovascular diseases to drive the market growth
TABLE 20 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 21 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2018–2025 (MILLION UNITS)
  6.3.4 ECG/EKG DEVICES
    6.3.4.1 High prevalence of cardiovascular diseases to drive the market
TABLE 22 ECG/EKG DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.5 OVULATION AND PREGNANCY TEST KITS
    6.3.5.1 Privacy, convenience, accessibility, and quick results to drive the market for ovulation and pregnancy test kits
TABLE 23 OVULATION AND PREGNANCY TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.6 PULSE OXIMETERS
    6.3.6.1 Pulse oximeters are used to measure the oxygen saturation
in the blood
TABLE 24 PULSE OXIMETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 25 PULSE OXIMETERS MARKET, BY REGION, 2018–2025 (MILLION UNITS)
  6.3.7 HEART RATE MONITORS
    6.3.7.1 Ability to continuously monitor the critical cardiac parameters
to drive the demand for heart rate monitors
TABLE 26 HEART RATE MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.8 COAGULATION MONITORING PRODUCTS
    6.3.8.1 Coagulation monitors are used for routine management of prothrombin time/international normalized ratio for the
safe and effective management
TABLE 27 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.9 FETAL MONITORING DEVICES
    6.3.9.1 High risk of preterm birth to drive the market for fetal
monitoring devices
TABLE 28 FETAL MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.10 HIV TEST KITS
    6.3.10.1 Rising prevalence of HIV to drive the market
TABLE 29 HIV TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.11 HOLTER AND EVENT MONITORS
    6.3.11.1 Rising awareness of preventive care and technological advancements to drive the market
TABLE 30 HOLTER AND EVENT MONITORS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.12 TEMPERATURE MONITORING DEVICES
    6.3.12.1 Technological innovations and increasing awareness on the use
of temperature monitoring devices for personal care to drive
the growth of this market
TABLE 31 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.13 CHOLESTEROL TESTING PRODUCTS
    6.3.13.1 Rising obesity levels and cardiovascular disorder incidence
are the key factors supporting the market growth
TABLE 32 CHOLESTEROL MONITORING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.14 DRUG AND ALCOHOL TEST KITS
    6.3.14.1 Consumption of drugs among teens supports the market growth
TABLE 33 DRUG AND ALCOHOL TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.15 PEAK FLOW METERS
    6.3.15.1 Peak flow meters are used to monitor the person’s ability to breathe
TABLE 34 PEAK FLOW METERS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.16 COLON CANCER TEST KITS
    6.3.16.1 High incidence of colorectal cancer to support the market growth
TABLE 35 COLON CANCER TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.17 ACTIVITY MONITORS & WRIST BANDS
    6.3.17.1 Increasing prevalence of chronic diseases has resulted in a significant increase in the demand for activity monitors
TABLE 36 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.18 EEG DEVICES
    6.3.18.1 Emergence of epilepsy as a common neurological condition to drive the market for EEG devices
TABLE 37 EEG DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.19 HOME SLEEP TESTING DEVICES
    6.3.19.1 Cost-effectiveness of home-based sleep tests expected to fuel the growth of home sleep testing devices
TABLE 38 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.3.20 HOME HEMOGLOBIN A1C TEST KITS
    6.3.20.1 High incidence of diabetes to drive the market
TABLE 39 HOME HEMOGLOBIN A1C TEST KITS MARKET, BY REGION, 2018–2025 (USD MILLION)
6.4 HOME HEALTHCARE MOBILITY CARE PRODUCTS
TABLE 40 HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 41 HOME HEALTHCARE MARKET FOR MOBILITY CARE PRODUCTS, BY REGION, 2018–2025 (USD MILLION)
  6.4.1 WHEELCHAIRS
    6.4.1.1 Increased preference for wheelchairs to support the market growth
TABLE 42 WHEELCHAIRS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.4.2 MOBILITY SCOOTERS
    6.4.2.1 Mobility scooters help users to travel long distances
TABLE 43 MOBILITY SCOOTERS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.4.3 WALKERS AND ROLLATORS
    6.4.3.1 Walkers are used by the disabled and the elderly for additional support while walking
TABLE 44 WALKERS AND ROLLATORS MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.4.4 CRUTCHES
    6.4.4.1 Axilla crutches are the most preferred as they are easy to use
and are often used by people who have a temporary injury
TABLE 45 CRUTCHES MARKET, BY REGION, 2018–2025 (USD MILLION)
  6.4.5 CANES
    6.4.5.1 Canes are the most common assistive devices
TABLE 46 CANES MARKET, BY REGION, 2018–2025 (USD MILLION)

7 HOME HEALTHCARE MARKET, BY SERVICE

7.1 INTRODUCTION
TABLE 47 US: AVERAGE SENIOR CARE COST, BY TYPE AND DURATION, 2019
TABLE 48 HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD BILLION)
TABLE 49 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
7.2 SKILLED NURSING
  7.2.1 SKILLED NURSING SERVICES TO DOMINATE THE HOME HEALTHCARE SERVICES MARKET DURING THE FORECAST PERIOD
TABLE 50 SKILLED NURSING SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
7.3 REHABILITATION THERAPY
  7.3.1 REHABILITATION THERAPY SERVICES MAJORLY INCLUDE PHYSIOTHERAPY, OCCUPATIONAL THERAPY, AND SPEECH THERAPY
TABLE 51 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
7.4 HOSPICE AND PALLIATIVE CARE
  7.4.1 RISING GERIATRIC POPULATION TO DRIVE HOSPICE AND PALLIATIVE
CARE SERVICES
TABLE 52 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
7.5 UNSKILLED CARE
  7.5.1 UNSKILLED CARE SERVICES ARE COST-EFFECTIVE AND OFFER
COMFORT AND SECURITY TO PATIENTS
TABLE 53 UNSKILLED CARE SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
7.6 RESPIRATORY THERAPY
  7.6.1 THE GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE THE MARKET
TABLE 54 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2018–2025 (USD BILLION)
7.7 INFUSION THERAPY
  7.7.1 HOME INFUSION IS A SAFE AND EFFECTIVE ALTERNATIVE TO IN-PATIENT CARE FOR VARIOUS DISEASE STATES AND THERAPIES
TABLE 55 INFUSION THERAPY SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
7.8 PREGNANCY CARE
  7.8.1 PREGNANCY CARE SERVICES HELP EXPECTANT PARENTS TO MANAGE
HIGH-RISK PREGNANCIES AND COMPLICATIONS
TABLE 56 PREGNANCY CARE SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)

8 HOME HEALTHCARE MARKET, BY INDICATION

8.1 INTRODUCTION
TABLE 57 HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD BILLION)
8.2 CANCER
  8.2.1 HIGH PREVALENCE OF CANCER TO DRIVE THE MARKET GROWTH
TABLE 58 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2018–2025 (USD BILLION)
8.3 RESPIRATORY DISEASES
  8.3.1 RISING PREVALENCE OF RESPIRATORY DISEASES TO HAVE A POSITIVE IMPACT ON THIS SEGMENT
TABLE 59 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2018–2025 (USD BILLION)
8.4 MOVEMENT/MOBILITY DISORDERS
  8.4.1 AGING IS A RISK FACTOR FOR MOVEMENT DISORDERS
TABLE 60 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2018–2025 (USD BILLION)
8.5 CARDIOVASCULAR DISORDERS & HYPERTENSION
  8.5.1 RISING INCIDENCE OF HYPERTENSION AND CARDIOVASCULAR DISORDERS TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 61 HOME HEALTHCARE MARKET FOR CARDIOVASCULAR DISORDERS & HYPERTENSION, BY REGION, 2018–2025 (USD BILLION)
8.6 PREGNANCY
  8.6.1 RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY
TO DRIVE THE GROWTH OF THIS SEGMENT
TABLE 62 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2018–2025 (USD BILLION)
8.7 WOUND CARE
  8.7.1 RISING PREVALENCE OF ROAD ACCIDENTS AND TRAUMA INJURIES
DRIVE THE MARKET GROWTH
TABLE 63 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2018–2025 (USD BILLION)
8.8 DIABETES
  8.8.1 INCREASING INCIDENCE OF DIABETES TO DRIVE THE GROWTH OF THIS MARKET
TABLE 64 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2018–2025 (USD BILLION)
8.9 HEARING DISORDERS
  8.9.1 AGING IS ONE OF THE RISK FACTORS FOR HEARING DISORDERS
TABLE 65 GLOBAL INCIDENCE OF HEARING DISORDERS
TABLE 66 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2018–2025 (USD BILLION)
8.10 OTHER INDICATIONS
TABLE 67 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2018–2025 (USD BILLION)

9 HOME HEALTHCARE MARKET, BY REGION

9.1 INTRODUCTION
TABLE 68 HOME HEALTHCARE MARKET, BY REGION, 2018–2025 (USD BILLION)
9.2 NORTH AMERICA
TABLE 69 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
FIGURE 20 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
TABLE 70 NORTH AMERICA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD BILLION)
TABLE 71 NORTH AMERICA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 NORTH AMERICA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 73 NORTH AMERICA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 NORTH AMERICA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 NORTH AMERICA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD BILLION)
TABLE 76 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD BILLION)
  9.2.1 US
    9.2.1.1 US to dominate the North American home healthcare market
TABLE 77 US: KEY INDICATORS
TABLE 78 US: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD BILLION)
TABLE 79 US: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 US: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 81 US: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 US: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 83 US: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 84 US: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD BILLION)
  9.2.2 CANADA
    9.2.2.1 Rising aging population drives the market in the country
TABLE 85 CANADA: KEY INDICATORS
TABLE 86 CANADA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 CANADA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 CANADA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 CANADA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 90 CANADA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 CANADA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
9.3 EUROPE
TABLE 93 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY/REGION, 2018–2025 (USD BILLION)
TABLE 94 EUROPE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 EUROPE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 96 EUROPE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 EUROPE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 EUROPE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 EUROPE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.3.1 GERMANY
    9.3.1.1 Germany to dominate the European Home Healthcare Market
TABLE 101 GERMANY: KEY INDICATORS
TABLE 102 GERMANY: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 GERMANY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 GERMANY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 GERMANY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 106 GERMANY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 107 GERMANY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 108 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.3.2 FRANCE
    9.3.2.1 Government support and initiatives taken by market players
to drive the home healthcare market
TABLE 109 FRANCE: KEY INDICATORS
TABLE 110 FRANCE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 111 FRANCE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 112 FRANCE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 113 FRANCE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 114 FRANCE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 115 FRANCE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.3.3 UK
    9.3.3.1 High burden of chronic diseases to drive the market in the country
TABLE 117 UK: KEY INDICATORS
TABLE 118 UK: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 119 UK: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 120 UK: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 UK: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 UK: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 UK: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 124 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.3.4 ITALY
    9.3.4.1 Rising geriatric population and the favorable government
policy to drive the market in the country
TABLE 125 ITALY: KEY INDICATORS
TABLE 126 ITALY: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 ITALY: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 ITALY: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 ITALY: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 130 ITALY: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 131 ITALY: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 132 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.3.5 SPAIN
    9.3.5.1 Increasing chronic conditions coupled with higher life expectancy
to drive the market in the country
TABLE 133 SPAIN: KEY INDICATORS
TABLE 134 SPAIN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 135 SPAIN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 136 SPAIN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 137 SPAIN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 138 SPAIN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 139 SPAIN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 140 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.3.6 REST OF EUROPE
    9.3.6.1 Growth in the target patient population to drive the market
in the region
TABLE 141 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2016 (% OF GDP)
TABLE 142 ROE: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 143 ROE: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 144 ROE: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 145 ROE: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 146 ROE: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 147 ROE: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 148 ROE: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
9.4 ASIA PACIFIC
TABLE 149 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2018–2025 (USD BILLION)
FIGURE 21 ASIA PACIFIC: HOME HEALTHCARE MARKET SNAPSHOT
TABLE 150 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 151 ASIA PACIFIC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 152 ASIA PACIFIC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 153 ASIA PACIFIC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 154 ASIA PACIFIC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 155 ASIA PACIFIC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 156 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.4.1 JAPAN
    9.4.1.1 Growing geriatric population in the country to drive the
home healthcare market
TABLE 157 JAPAN: KEY INDICATORS
TABLE 158 JAPAN: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 159 JAPAN: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 160 JAPAN: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 161 JAPAN: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 162 JAPAN: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 163 JAPAN: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 164 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.4.2 CHINA
    9.4.2.1 Healthcare development and reforms will drive the market
in the country
TABLE 165 CHINA: KEY INDICATORS
TABLE 166 CHINA: HOME HEALTHCARE MARKET, BY TYPE, 2015–2022 (USD MILLION)
TABLE 167 CHINA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 168 CHINA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 169 CHINA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 170 CHINA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 171 CHINA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 172 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.4.3 INDIA
    9.4.3.1 Increasing target patient population to drive the market
in the country
TABLE 173 INDIA: KEY INDICATORS
TABLE 174 INDIA: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 175 INDIA: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 176 INDIA: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 177 INDIA: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 178 INDIA: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 179 INDIA: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 180 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
  9.4.4 REST OF ASIA PACIFIC
TABLE 181 ROAPAC: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 182 ROAPAC: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 183 ROAPAC: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 184 ROAPAC: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 185 ROAPAC: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 186 ROAPAC: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 187 ROAPAC: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 188 ROW: HOME HEALTHCARE MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 189 ROW: HOME HEALTHCARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 190 ROW: HOME HEALTHCARE TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 191 ROW: HOME HEALTHCARE THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 192 ROW: HOME HEALTHCARE MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 193 ROW: HOME HEALTHCARE SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 194 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2018–2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW
FIGURE 22 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020
FIGURE 23 MARKET EVOLUTION FRAMEWORK
10.2 MARKET SHARE ANALYSIS, 2019
FIGURE 24 HOME BLOOD PRESSURE MONITORS MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 25 GLOBAL HEARING AID MARKET SHARE, BY KEY PLAYER, 2019
FIGURE 26 HOME DIALYSIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2019
10.3 COMPETITIVE SCENARIO
  10.3.1 PARTNERSHIPS, AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES (2017–2020)
  10.3.2 PRODUCT LAUNCHES & APPROVALS (2017-2020)
  10.3.3 EXPANSIONS (2017-2020)
  10.3.4 ACQUISITIONS (2017-2020)
10.4 COMPANY EVALUATION QUADRANT (2020)
  10.4.1 VENDOR INCLUSION CRITERIA
  10.4.2 STAR
  10.4.3 EMERGING LEADERS
  10.4.4 PERVASIVE
  10.4.5 PARTICIPANT
FIGURE 27 MNM VENDOR DIVE COMPARISON MATRIX: HOME HEALTHCARE MARKET
10.5 COMPETITIVE LEADERSHIP MAPPING (START-UPS) FOR THE HOME HEALTHCARE SERVICES MARKET
  10.5.1 PROGRESSIVE COMPANIES
  10.5.2 STARTING BLOCKS
  10.5.3 RESPONSIVE COMPANIES
  10.5.4 DYNAMIC COMPANIES
FIGURE 28 MNM VENDOR DIVE COMPARISON MATRIX FOR START-UPS: HOME HEALTHCARE MARKET

11 COMPANY PROFILES

(Business Overview, products & services offered, Recent Developments, MnM View)*
11.1 FRESENIUS
FIGURE 29 FRESENIUS: COMPANY SNAPSHOT (2019)
TABLE 195 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EURO TO USD)
11.2 GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
FIGURE 30 GENERAL ELECTRIC COMPANY SNAPSHOT: COMPANY SNAPSHOT (2019)
11.3 LINDE PLC
FIGURE 31 LINDE PLC: COMPANY SNAPSHOT (2019)
11.4 ROCHE
FIGURE 32 ROCHE: COMPANY SNAPSHOT (2019)
TABLE 196 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF CHF TO USD)
11.5 A&D COMPANY
FIGURE 33 A&D COMPANY: COMPANY SNAPSHOT (2019)
TABLE 197 EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF JPY TO USD)
11.6 BAYADA HOME HEALTH CARE
11.7 INVACARE CORPORATION
FIGURE 34 INVACARE CORPORATION: COMPANY SNAPSHOT (2019)
11.8 ABBOTT LABORATORIES
FIGURE 35 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
11.9 AMEDISYS
FIGURE 36 AMEDISYS: COMPANY SNAPSHOT (2019)
11.10 KINDRED AT HOME
11.11 LHC GROUP
FIGURE 37 LHC GROUP: COMPANY SNAPSHOT (2019)
11.12 OMRON CORPORATION
FIGURE 38 OMRON CORPORATION: COMPANY SNAPSHOT (2019)
11.13 KONINKLIJKE PHILIPS N.V.
FIGURE 39 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2019)
11.14 DRIVE DEVILBISS HEALTHCARE
11.15 HAMILTON MEDICAL AG
*Details on Business Overview, products & services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
11.16 SUNRISE MEDICAL
11.17 ROMA MEDICAL
11.18 CAREMAX REHABILITATION EQUIPMENT CO., LTD.
11.19 VITALOGRAPH
11.20 ADVITA PFLEGEDIENST GMBH
11.21 RENAFAN GMBH
11.22 ADMR
11.23 APEX MEDICAL CORP.
11.24 CONTEC MEDICAL SYSTEMS CO., LTD
11.25 L?WENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS


More Publications